dichlororibofuranosylbenzimidazole has been researched along with Dysembryoma in 2 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, RS | 1 |
| Hodgson, M | 1 |
| Wang, SY | 1 |
| Gudas, LJ | 1 |
2 other studies available for dichlororibofuranosylbenzimidazole and Dysembryoma
| Article | Year |
|---|---|
Genetic markers in mouse teratocarcinoma cells. Selection and partial characterization of mutants resistant to toyocamycin, DRB and podophyllotoxin.
Topics: Adenosine Kinase; Animals; Cell Line; Dichlororibofuranosylbenzimidazole; Drug Resistance; Genetic M | 1981 |
Protein synthesis inhibitors prevent the induction of laminin B1, collagen IV (alpha 1), and other differentiation-specific mRNAs by retinoic acid in F9 teratocarcinoma cells.
Topics: Animals; Aphidicolin; Bucladesine; Cell Line; Collagen; Dichlororibofuranosylbenzimidazole; Diterpen | 1988 |